Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.

RPEP-027022015RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.
Published In:
The Journal of clinical endocrinology and metabolism, 100(2), 697-706 (2015)
Database ID:
RPEP-02702

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-02702·https://rethinkpeptides.com/research/RPEP-02702

APA

Leder, Benjamin Z; O'Dea, Louis St L; Zanchetta, José R; Kumar, Prasana; Banks, Kathleen; McKay, Kathleen; Lyttle, C Richard; Hattersley, Gary. (2015). Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.. The Journal of clinical endocrinology and metabolism, 100(2), 697-706. https://doi.org/10.1210/jc.2014-3718

MLA

Leder, Benjamin Z, et al. "Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.." The Journal of clinical endocrinology and metabolism, 2015. https://doi.org/10.1210/jc.2014-3718

RethinkPeptides

RethinkPeptides Research Database. "Effects of abaloparatide, a human parathyroid hormone-relate..." RPEP-02702. Retrieved from https://rethinkpeptides.com/research/leder-2015-effects-of-abaloparatide-a

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.